Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 3,405 | 4,203 | 4,350 | 4,652 | 4,774 |
| Operating Income | -3,405 | -4,203 | -4,350 | -4,652 | -4,774 |
| Other Income | 76 | 129 | 172 | 321 | 237 |
| Pre-tax Income | -3,329 | -4,074 | -4,177 | -4,331 | -4,537 |
| Net Income Continuous | -3,329 | -4,074 | -4,177 | -4,331 | -4,537 |
| Net Income | $-3,329 | $-4,074 | $-4,177 | $-4,331 | $-4,537 |
| EPS Basic Total Ops | -0.30 | -0.36 | -0.39 | -0.40 | -0.42 |
| EPS Basic Continuous Ops | -0.30 | -0.36 | -0.39 | -0.40 | -0.42 |
| EPS Diluted Total Ops | -0.30 | -0.36 | -0.39 | -0.40 | -0.42 |
| EPS Diluted Continuous Ops | -0.30 | -0.36 | -0.39 | -0.40 | -0.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.36 | -0.39 | -0.40 | -0.42 |
| EBITDA(a) | $-3,401 | $-4,224 | $-4,384 | $-4,780 | $-4,770 |